Kern Chang
Chief Technical Officer Lotte Biologics
Seminars
Monday 12th October 2026
Accelerating Bioconjugate Development & Manufacturing With LOTTE BIOLOGICS’ ADC Platform
3:00 pm
- Exploring a state-of-the art facility for ADC development and GMP manufacturing with completed conjugation process optimization and scale up studies across conjugation chemistries
- Developing a proprietary hydrophilic linker technology SoluFlex Link designed to enable favorable physicochemical and pharmacological ADC properties
- Establishing a flexible and scalable system to accelerate ADC translation into GMP compliant materials, supporting rapid clinical progression and ultimately commercial supply
